• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TAEWOONG MEDICAL CO.,LTD. NITI-S ESOPHAGEAL COVERED STENT; ESOPHAGEAL STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TAEWOONG MEDICAL CO.,LTD. NITI-S ESOPHAGEAL COVERED STENT; ESOPHAGEAL STENT Back to Search Results
Model Number EC1810BH
Device Problem Insufficient Information (3190)
Patient Problems Erosion (1750); Hemorrhage/Bleeding (1888)
Event Date 10/13/2020
Event Type  Injury  
Manufacturer Narrative
It was reported that 3 months after stent placement at mid-lower esophagus, in-growth and bleeding were confirmed.It was confirmed from the device history record that device had been manufactured with no significant issues and passed all the inspections successfully.Esophageal structure where stent implanted is the part with active peristalsis.It is possible that the stent could be pressed and stent in/over-growth could occur by state of patient's lesion.However, it is hard to identify the exact root cause since it is hard to reconstruct the situation at the time of procedure.It is hard to identify the exact cause since it is hard to reconstruct the situation at the time of procedure and the device was not returned and the information such as photo was not provided.However, based on the description "3 months after stent placement, in-growth and bleeding were confirmed", it is assumed that the stent in-growth occurred due to pressure of the patient lesion, peristalsis and foreign substance.Also, based on the description, it is assumed that the bleeding occurred due to the procedure process, but it is hard to identify the exact cause since it is hard to reconstruct the situation at the time of procedure and the procedure information was not enough.Through the user manual by taewoong, it is stated that "potential complications associated with the use of niti-s & comvi stent may include, but are not limited to: stent occlusion, tumor in-growth, bleeding".This suspected device is not registered in the us but we will continuously monitor the same or similar customer complaints through accurate analyses.
 
Event Description
On (b)(6) 2020: ec1810bh was placed at mid-lower esophagus due to esophageal cancer.On (b)(6) 2020: in-growth and bleeding were confirmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NITI-S ESOPHAGEAL COVERED STENT
Type of Device
ESOPHAGEAL STENT
Manufacturer (Section D)
TAEWOONG MEDICAL CO.,LTD.
14, gojeong-ro
wolgot-myeon
gimpo-si, gyeonggi-do 10022
KS  10022
Manufacturer (Section G)
TAEWOONG MEDICAL CO.,LTD.
14, gojeong-ro
wolgot-myeon
gimpo-si, gyeonggi-do 10022
KS   10022
Manufacturer Contact
lee
14, gojeong-ro
wolgot-myeon
gimpo-si, gyeonggi-do 10022
MDR Report Key10827153
MDR Text Key217668308
Report Number3003902943-2020-00098
Device Sequence Number1
Product Code ESW
Combination Product (y/n)Y
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 10/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/12/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/13/2022
Device Model NumberEC1810BH
Was Device Available for Evaluation? No
Date Manufacturer Received10/19/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/14/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-